Skip to content
CharitiesAidWelfare, Medical Health Aged Care

Blood cancer patients and families hit by perfect storm

Leukaemia Foundation / World's Greatest Shave 4 mins read

 

The Leukaemia Foundation is today casting the spotlight on concerning figures showing the significant financial distress blood cancer patients and their families are currently facing in Australia.

 

Research shows that more than 8,300 (43%) of the 19,500 patients diagnosed with blood cancer in the past year, experienced out of pocket treatment costs totalling hundreds, and sometimes thousands of dollars[i].

 

Adding to the financial hardship is the fact that around 8,200 (42%) of patients had to take over three months off work during treatment, 5,800 (30%) had to leave their jobs entirely, and over 9,700 (50%) have not yet been able to return to work[ii].

 

According to Leukaemia Foundation CEO, Chris Tanti, this combination of out-of-pocket expenses and the inability to work during or following blood cancer treatment, is having a dire financial impact on blood cancer patients and their families, creating a perfect storm for financial distress.

 

“Blood cancer is one the nation’s most expensive cancers to treat, creating a significant and sudden financial burden on those Australians diagnosed, and our health system,” said Mr Tanti.

 

“With incidence on the rise, we’re seeing a shocking number of patients, and their families, reaching out to us for support as the disease financially cripples them, sometimes within weeks.

 

“We are currently helping patients and families who are being forced use savings, sell assets including cars and homes, or turn to charity food boxes and food banks to survive.

 

“What’s also distressing, is the fact that these people are often immediately thrown into lifesaving treatment, leaving little or no time to get their financial affairs in order, or to work out how they are going to support themselves or their loved ones at home.”

 

In 2024, an estimated 19,500 further Australians will be diagnosed with blood cancer, including leukaemia, lymphoma, and myeloma, and this figure is set to nearly double by 2035[iii].

 

“Many Australians are already doing it tough with the rising cost of living but imagine being told you have blood cancer on top of this.

“For the 53 people diagnosed with blood cancer each day[iv], it’s another financial hit to them at a time when they need to focus on their health and surviving their diagnosis.”

 

The weighted average out-of-pocket costs to an individual with blood cancer ranges from $5,000-$11,000, compared with other cancer patients who incur around $2,500 in out-of-pocket costs[v].

 

Blood cancers myeloma and leukaemia account for two of the top five costliest cancers in the country to treat[vi], with myeloma alone costing the health system about $46,000 per individual, per year, almost triple the average cost incurred by other cancer patients in Australia[vii].

 

The distinctive features of blood cancer treatment often lead to radical disruptions to patient and family life, involving long hospital stays and the need to relocate to a capital city to access specialist treatment, further impacting patients’ ability to work, or to keep their jobs.

 

“Every day we hear from blood cancer patients who are struggling to financially survive due to the cost they bear from their diagnosis.

 

“With the rising cost of medical expenses, utility bills, and daily essentials, plus the exuberant cost of rent and mortgages, it's no wonder that when you couple this with the significant loss of income patients face when diagnosed, that many are doing it tough.”

 

In the past year, the Leukaemia Foundation has experienced a 36% increase in people living with blood cancer reaching out for financial assistance, with many turning to the charity to help make ends meet.

 

As the financial burden deepens, the Leukaemia Foundation is reaching out to Australians for help and urging them to get behind this year's World’s Greatest Shave.

 

“As a charity that receives no on-going government funding, we heavily rely on the generosity of the Australian community so we can assist blood cancer patients and their loved ones, through this incredibly difficult time.

 

“If we are to have any hope of easing the financial burden of blood cancer on those impacted, we desperately need more people to sign up to shave, cut, or colour their hair this March.

 

“We know that the World’s Greatest Shave alone is not going to solve the problem, but it’s certainly going to make a significant difference to the support we can provide to patients, and their families, right now when they need it most,” added Mr Tanti.

 

Every strand of hair Australians change in this year’s World’s Greatest Shave, will help support fellow Australians currently facing blood cancer.

 

To register to participate in the World’s Greatest Shave this March, sign up now via worldsgreatestshave.com or call 1800 500 088.  

 

-END-

 

*Please note – we will endeavour to find a suitable person financially impacted by blood cancer in your local area or a close radius, but with blood cancer patients located across the country this may not always be possible.



About us:

About the Leukaemia Foundation: The Leukaemia Foundation stands with Australia to help cure and conquer blood cancer – with care. Together we are attacking every blood cancer, from every direction, in every way we can. We stand beside every Australian to be their voice and their someone-to-turn to, fighting to get them access to the best care. We also accelerate research that is delivering rapid advancements in blood cancer diagnosis and treatments. Plus, we provide services and support that empower people living with any blood cancer to live well after diagnosis. You can learn more about the Leukaemia Foundation and blood cancer at leukaemia.org.au 


Contact details:

Contact our media team - [email protected]

Media

More from this category

  • Medical Health Aged Care, Research Development
  • 11/07/2025
  • 16:28
The Florey

Harnessing mRNA to prevent and slow Alzheimer’s disease

mRNA Victoria funds 2Floreyprojects to prevent and treat Alzheimer’s disease Key points mRNA Victoria has funded 2 Alzheimer’s disease research projects that could position Victoria as a leader in the development of mRNA-based therapies. Dr Abdel Belaidi will develop an mRNA-based system that crosses the blood-brain barrier and aims to slow or even halt disease progression. Dr Rebecca Nisbet will develop an mRNA vaccine that aims to prevent Alzheimer’s disease from developing. Florey researchers working at the cutting edge of dementia research have received funding from mRNA Victoria to develop treatments and a vaccine for Alzheimer’s disease. Since mRNA vaccines…

  • Medical Health Aged Care
  • 11/07/2025
  • 07:05
Royal Australian College of GPs

GPs urge Tasmanian families to get vaccinated against whooping cough and call for free shots to reduce barriers

The Royal Australian College of GPs (RACGP) is urging Tasmanian families to get vaccinated against pertussis, or ‘whooping cough’ and called on all parties and candidates running in the state election to commit to making the vaccination free for all patients. From 1 January 2024 to April 2025, 1238 whooping cough cases were notified in Tasmania, including 10 infants aged under six months. Most hospitalisations and deaths occur in this group, who are not old enough to have received all vaccine doses. More than 21,000 infections were recorded nationwide last year, compared to just 2450 in 2023, and the National…

  • Contains:
  • General News, Medical Health Aged Care
  • 11/07/2025
  • 07:00
La Trobe University

La Trobe researchers awarded $4.5 million in ARC Future Fellowships

LaTrobe University researchers have secured almost $4.5 million in Federal Government funding to further studies into areas such as immune cell development, Australian history and agriculture. Four researchers received an Australian Research Council (ARC) Future Fellowship 2025. The prestigious Future Fellowships support high quality research in areas of national and international benefit, including in national research priorities. Dr Lisa Mielke, from the School of Cancer Medicine, the La Trobe Institute of Molecular Science (LIMS) and the Olivia Newton-John Cancer Research Institute (ONJCRI), received $1.13 million to identify new molecules for future drug and vaccine development to improve gut health in…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.